February 27th Options Now Available For Philip Morris International

Philip Morris International (PM) is quoted at $158.79 and Stock Options Channel highlights two option strategies: selling a $155 put (bid $4.70) which nets a $150.30 cost basis and carries a 61% chance to expire worthless, producing a 3.03% return (22.14% annualized) if it does; and writing a covered call at the $165 strike (bid $2.75) which yields a 5.64% total return to the Feb. 27 expiration or a 1.73% premium boost (12.64% annualized) if the call expires worthless (63% odds). Implied volatility is 29% on the put and 27% on the call versus a 12‑month trailing volatility of 26%, framing these as modestly income-generating, tactical option ideas rather than company-specific fundamental news.

Analysis

Market structure: The immediate winners are option premium sellers and long-term PM equity buyers willing to harvest yield via covered calls or cash‑secured puts; brokers and volatility sellers benefit from consistent premium flow. The presented 155 put (bid $4.70) and 165 call (bid $2.75) imply modest risk transfer: sellers collect ~3.03% (22.1% annualized) or 1.73% (12.6% annualized) for a 1–2% OTM exposure versus current price $158.79, signaling a market view of limited near‑term move (IV 27–29% vs realized 26%).

Risk assessment: Tail risks include regulatory/legal shocks (FDA rulings, flavor bans), currency shocks in emerging markets, or a litigation settlement that could erase >20% market cap; these are low‑probability but high‑impact over 3–12 months. Near‑term (days–weeks) risks are IV spikes around earnings or FX moves; medium‑term (months) risks are sales volume declines and margin pressure; long term (years) is secular decline in combustible tobacco demand and product transition execution.

Trade implications: For tactical income, cash‑secured put (sell Feb 27 155) or covered call (buy at $158.8 + sell 165 Feb 27) are efficient if comfortable owning 100 shares at $150.30 effective; prefer defined‑risk alternatives (155/145 put credit spread) if you want capped downside. For portfolio construction, overweight tobacco/stable consumer staples by 1–3% only if funding a high‑conviction hedged position (collar or put spread) and use 3–6 month horizons to harvest theta.

Contrarian angles: Consensus underestimates regulatory tail risk and the asymmetric loss in share value; IV modestly above realized implies complacency—a single adverse FDA/legal outcome could push IV >50% and repricing >20%. Conversely, if PM reports stable shipments and nicotine‑reduction headwinds fade, selling short‑dated premium ahead of events offers dislocation alpha; historic parallels: post‑policy selloffs in 2015–2018 recovered over 6–12 months when fundamentals held.

Key Decisions for Investors

• Sell cash‑secured PM Feb 27 155 put (collect ~$4.70) sized so max assignment equals 1% of portfolio (obligation = $15,500 per contract). Close or roll if PM < 148 or if IV rises >35% within 30 days to limit unexpected assignment losses.
• Buy 100 PM shares at ~$158.8 and sell Feb 27 165 covered call (collect ~$2.75) for a target 5–6% return to Feb expiry; if PM rises >170, buy back call and re‑establish at higher strike; if PM falls below 150, exit covered call or convert to a collar (buy 145 put) to cap losses.
• Use defined‑risk put credit spread instead of naked puts: sell Feb 27 155 / buy 145 put (width $10) to limit downside to $10 less net credit; target net credit >= $2.00 (implied RR ~5:1) and avoid assignment while harvesting theta over 1–3 months.
• Establish a hedged relative trade if seeking alpha: go long PM and short MO (Altria) 1:1 for 3–6 months to isolate international growth/FX vs U.S. domestic regulatory exposure; size at 0.5–1% net portfolio exposure and trim if spread widens >7%.